Investigation of MDR1 Gene Polymorphism and Losartan Plasma Concentration in Patients Undergoing Hypertensive Episodes While Under Losartan Treatment

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

October 23, 2017

Primary Completion Date

January 15, 2019

Study Completion Date

January 15, 2019

Conditions
Hypertension
Interventions
DIAGNOSTIC_TEST

Genetic analysis and Losartan plazma level measurement

20 ml of blood was collected from the enrolled patients. 10 ml of blood was stored in the tubes with ethylene diamine tetraacetic acid (EDTA) until Deoxyribonucleic acid (DNA) isolation was performed at -20 degrees and plasma level was identified. The remaining 10 ml was centrifuged at 3500 rpm for 10 min, and the plasma was separated. The resulting plasmas were stored in the eppendorf tubes at -20°C until the tandem mass spectrometry measurement. The blood samples in EDTA tubes were then transferred for DNA analysis. . To measure plasma losartan concentration, after the frozen plasma samples stored in the eppendorfs were thawed and brought to room temperature, plasma losartan and EXP3174 levels of the patients were calculated using tandem mass spectrometry

Trial Locations (1)

06560

Gazi University, Ankara

All Listed Sponsors
collaborator

Gazi University

OTHER

lead

Pamukkale University

OTHER

NCT05349825 - Investigation of MDR1 Gene Polymorphism and Losartan Plasma Concentration in Patients Undergoing Hypertensive Episodes While Under Losartan Treatment | Biotech Hunter | Biotech Hunter